BOOST Pharma
boostpharma.com
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
BOOST Pharma Selected to Showcase Phase III Ready Lead Program BT-101 at the 2026 Cell & Gene Meeting on the Mesa
BOOST Pharma (
Read more
Report
BOOST Pharma selected to showcase Phase III-ready BT-101 at 2026 Cell & Gene Meeting on the Mesa
BOOST Pharma has been selected as a 2026 Innovation Spotlight company at the Cell & Gene Meeting on the Mesa, where CEO Hans Schambye will present an update on BT-101 and preparations for its planned pivotal Phase III study. Presentation DetailsDate and T
Read more
Report
BOOST Pharma presents BT-101 at RESI San Diego 2026
BOOST Pharma CEO Hans T. Schambye presented an update on BT-101 at RESI San Diego 2026. The presentation highlighted BOOST Pharma's development of BT-101 for severe pediatric Osteogenesis Imperfecta (OI) and the program's progression toward pivotal Phase
Read more
Report
BOOST Pharma presents at the 3rd ATMP Mini-Symposium in Lund
BOOST Pharma Co-founder and Chief Development Officer Lilian Walther Jallow presented at the 3rd ATMP Mini-Symposium at Lund University. Lilian shared BOOST Pharma's work advancing BT-101 for severe pediatric Osteogenesis Imperfecta (OI), including the ac
Read more
Report
Elaine Jones Appointed as Board Chair of BOOST Pharma
Elaine Jones is a seasoned life science investor, executive and board leader to support next phase of growth as BOOST Pharma advances BT-101. Read full press release (PDF) The post Elaine Jones Appointed as Board Chair of BOOST Pharma appeared first on BO
Read more
Report
Hans Schambye Appointed as Chief Executive Officer of BOOST Pharma
Hans Schambye is a highly regarded biotech entrepreneur and operator with a proven record in building and leading companies from drug discovery to late-stage clinical development and pivotal value-creating milestones. Read full press release (PDF) The pos
Read more
Report